IP Library Granted Patent US 7,482,437
Granted Patent B2
US 7,482,437 · App. 11/670,467 · Granted Jan 27, 2009

Protease inhibitor conjugates and antibodies useful in immunoassay

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,482,437
App. No.
11/670,467
Granted
Jan 27, 2009
Kind
B2
Abstract

Activated haptens useful for generating immunogens to HIV protease inhibitors, immunogens useful for producing antibodies to HIV protease inhibitors, and antibodies and labeled conjugates useful in immunoassays for the HIV protease inhibitor saquinavir. The novel haptens feature an activated functionality at the central, non-terminal hydroxyl group. Also described are monoclonal antibodies specific for saquinavir having less than 10% cross-reactivity with lopinavir, nelfinavir, amprenavir, ritonavir, and indinavir, and a murine hybridoma producing said antibodies.

Claims (8)

1. A compound having the structure

2. A compound having the structure

3. A compound having the structure

wherein KLH is keyhole limpet hemocyanin and n is a number from 1 to 50 per 50 kilodaltons molecular weight of KLH.

4. A compound having the structure

wherein BSA is bovine serum albumin and n is a number from 1 to 50 per 50 kilodaltons molecular weight of BSA.

5. Murine hybridoma <INDIN> M 1.003.12 having DSMZ No. ACC2547.

6. Murine hybridoma <INDIN> M 1.158.8 having DSMZ No. ACC2546.